←
EndocrinologyAdvisor5,877 posts
EndocrinologyAdvisor avatar

EndocrinologyAdvisor

@EndoAdvisor

Endocrinology Advisor provides healthcare professionals with comprehensive information and clinical news on the management of endocrine conditions.

◷ Joined March 2014▧ 218 Photos and videos
EndocrinologyAdvisor avatar
EndocrinologyAdvisor@EndoAdvisor·Nov 16

The SURMOUNT-ADOLESCENTS trial, presented at #ObesityWeek2026, evaluated the efficacy and safety of #tirzepatide in adolescents with #obesity and weight-related conditions. bit.ly/4jl4Fvf

EndocrinologyAdvisor avatar
EndocrinologyAdvisor@EndoAdvisor·Nov 16

In an oral session at #ObesityWeek2026, researchers presented study results on the efficacy of combination eloralintide and #tirzepatide in the treatment of overweight or #obesity and type 2 diabetes. bit.ly/4A8bOFv

EndocrinologyAdvisor avatar
EndocrinologyAdvisor@EndoAdvisor·Nov 13

Out of 40M+ with #diabetes, up to 95% have type 2: 1️⃣ 38M diagnosed (11M unaware) 2️⃣ 88% have overweight/obesity 3️⃣ Highest in AI/AN (15.7%) & Black adults (12.2%) Biggest hurdle: screening or care access? Full data: bit.ly/3X1SElH #Type2Diabetes

0:20
EndocrinologyAdvisor avatar
EndocrinologyAdvisor@EndoAdvisor·Nov 10

The conventional IDAA1c cutoff of 9 demonstrates poor sensitivity for identifying partial remission in pediatric patients with type 1 #diabetes and comorbid overweight or #obesity, suggesting that weight-stratified thresholds may be necessary. bit.ly/4AqaIo9

EndocrinologyAdvisor avatar
EndocrinologyAdvisor@EndoAdvisor·Nov 9

Higher long-term glycemic exposure and the presence of microvascular complications are significantly associated with an elevated risk for #sleep disturbances among older patients with type 1 #diabetes. endocrinologyadvisor.com/new…